Literature DB >> 24512761

Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles.

Marina A Dobrovolskaia1, Barry W Neun2, Sonny Man2, Xiaoying Ye3, Matthew Hansen2, Anil K Patri2, Rachael M Crist2, Scott E McNeil2.   

Abstract

Proteins bound to nanoparticle surfaces are known to affect particle clearance by influencing immune cell uptake and distribution to the organs of the mononuclear phagocytic system. The composition of the protein corona has been described for several types of nanomaterials, but the role of the corona in nanoparticle biocompatibility is not well established. In this study we investigate the role of nanoparticle surface properties (PEGylation) and incubation times on the protein coronas of colloidal gold nanoparticles. While neither incubation time nor PEG molecular weight affected the specific proteins in the protein corona, the total amount of protein binding was governed by the molecular weight of PEG coating. Furthermore, the composition of the protein corona did not correlate with nanoparticle hematocompatibility. Specialized hematological tests should be used to deduce nanoparticle hematotoxicity. From the clinical editor: It is overall unclear how the protein corona associated with colloidal gold nanoparticles may influence hematotoxicity. This study warns that PEGylation itself may be insufficient, because composition of the protein corona does not directly correlate with nanoparticle hematocompatibility. The authors suggest that specialized hematological tests must be used to deduce nanoparticle hematotoxicity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coagulation; Complement; Hematocompatibility; Nanoparticles; Protein corona

Mesh:

Substances:

Year:  2014        PMID: 24512761      PMCID: PMC4125554          DOI: 10.1016/j.nano.2014.01.009

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  37 in total

1.  Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles.

Authors:  M Jansch; P Stumpf; C Graf; E Rühl; R H Müller
Journal:  Int J Pharm       Date:  2012-02-08       Impact factor: 5.875

2.  Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses.

Authors:  Zhou J Deng; Mingtao Liang; Istvan Toth; Michael Monteiro; Rodney F Minchin
Journal:  Nanotoxicology       Date:  2012-03-06       Impact factor: 5.913

3.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.

Authors:  Zhou J Deng; Mingtao Liang; Michael Monteiro; Istvan Toth; Rodney F Minchin
Journal:  Nat Nanotechnol       Date:  2010-12-19       Impact factor: 39.213

4.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Martina Foy; Tord Berggård; Seamas C Donnelly; Gerard Cagney; Sara Linse; Kenneth A Dawson
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 5.  Separation, detection and quantitation of peptides by liquid chromatography and capillary electrochromatography.

Authors:  Haleem J Issaq; King C Chan; Josip Blonder; Xiaoying Ye; Timothy D Veenstra
Journal:  J Chromatogr A       Date:  2008-12-25       Impact factor: 4.759

6.  The evolution of the protein corona around nanoparticles: a test study.

Authors:  Martin Lundqvist; Johannes Stigler; Tommy Cedervall; Tord Berggård; Michelle B Flanagan; Iseult Lynch; Giuliano Elia; Kenneth Dawson
Journal:  ACS Nano       Date:  2011-08-26       Impact factor: 15.881

7.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jiwen Zheng; Jeffrey D Clogston; Nader Ayub; Parag Aggarwal; Barry W Neun; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine       Date:  2008-12-13       Impact factor: 5.307

8.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

Authors:  Anja Zensi; David Begley; Charles Pontikis; Celine Legros; Larisa Mihoreanu; Sylvia Wagner; Claudia Büchel; Hagen von Briesen; Jörg Kreuter
Journal:  J Control Release       Date:  2009-03-11       Impact factor: 9.776

9.  Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.

Authors:  Raghav Goel; Neha Shah; Rachana Visaria; Giulio F Paciotti; John C Bischof
Journal:  Nanomedicine (Lond)       Date:  2009-06       Impact factor: 5.307

10.  Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles.

Authors:  D Patrick O'Neal; Leon R Hirsch; Naomi J Halas; J Donald Payne; Jennifer L West
Journal:  Cancer Lett       Date:  2004-06-25       Impact factor: 8.679

View more
  26 in total

Review 1.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

Review 2.  Hyperthermia using nanoparticles--Promises and pitfalls.

Authors:  Punit Kaur; Maureen L Aliru; Awalpreet S Chadha; Alexzander Asea; Sunil Krishnan
Journal:  Int J Hyperthermia       Date:  2016-01-12       Impact factor: 3.914

Review 3.  Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems Pharmacology.

Authors:  Jessie L-S Au; Roberto A Abbiati; M Guillaume Wientjes; Ze Lu
Journal:  Pharmacol Rev       Date:  2019-04       Impact factor: 25.468

Review 4.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

Review 5.  To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Authors:  Da Shi; Damian Beasock; Adam Fessler; Janos Szebeni; Julia Y Ljubimova; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2021-12-10       Impact factor: 15.470

6.  The Relevance of Physico-Chemical Properties and Protein Corona for Evaluation of Nanoparticles Immunotoxicity-In Vitro Correlation Analysis on THP-1 Macrophages.

Authors:  Mojca Pavlin; Jasna Lojk; Klemen Strojan; Iva Hafner-Bratkovič; Roman Jerala; Adrijana Leonardi; Igor Križaj; Nataša Drnovšek; Saša Novak; Peter Veranič; Vladimir Boštjan Bregar
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

Review 7.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

Review 8.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

9.  Impact of Anti-Biofouling Surface Coatings on the Properties of Nanomaterials and Their Biomedical Applications.

Authors:  Yuancheng Li; Yaolin Xu; Candace C Fleischer; Jing Huang; Run Lin; Lily Yang; Hui Mao
Journal:  J Mater Chem B       Date:  2017-10-30       Impact factor: 6.331

10.  A Protein Corona Adsorbed to a Bacterial Magnetosome Affects Its Cellular Uptake.

Authors:  Wenjia Lai; Dan Li; Qingsong Wang; Xiaohui Nan; Zhichu Xiang; Yan Ma; Ying Liu; Jiankui Chen; Jiesheng Tian; Qiaojun Fang
Journal:  Int J Nanomedicine       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.